Research

In February 2026, while many of us waited - quasi-patiently - for the coming of spring, cannabis-related equities featured predictably...

2025 marked another period of significant recalibration and transition for the regulated cannabis industry in the United States. While the...

Once again, cannabis-related equities began 2026 with weakness, extending CRBs’ multi-year underperformance relative to global, broad market indexes. Cannabis-themed benchmarks...

As has been the case for several years, stakeholders in the cannabis space were treated to a combination of legislative...

As we have done for nearly a decade, CRB Monitor provides our clients with the gold standard in cannabis and...

As we write this market commentary the US Federal Government recently ended a 40+-day shutdown due to a budgetary stalemate...

For the better part of the last five years, we have used this space to offer monthly commentary on the...

Please believe us, the chart below is not an AI-generated visualization. This performance really happened in August 2025 – where...

CRB Monitor of Nashville, TN is pleased to announce that its global database of  more than 1,600 cannabis-linked securities has...

Last month we wrote about some of the sources of risk in the cannabis equity realm, which include shrinking market...